According to Tim Hubbard, a computational biologist at the SangerCentre in Cambridge, England, the big question in protein modelling is why ab initio modelling has hitherto been so unsuccessful.
That was anathema to Dr Collins and his British counterpart, John Sulston (who was head of the Wellcome Trust's SangerCentre, now known as the Sanger Institute, which did about a third of the public project), who wanted genes to be public goods and started racing Celera to stop the firm finding genes first.